Why New York approval could accelerate Quest Diagnostics’ Haystack MRD cancer strategy
Quest Diagnostics has taken Haystack MRD nationwide after New York approval. See how ctDNA testing could reshape cancer recurrence monitoring.
Quest Diagnostics has taken Haystack MRD nationwide after New York approval. See how ctDNA testing could reshape cancer recurrence monitoring.
Visby’s at-home PCR STI test now on Quest and Labcorp. Find out how this redefines women’s health diagnostics and access. Read the full analysis.